USD $1.00-1.00 / Kilogram
USD $10.00-10.00 / Gram
USD $20.00-40.00 / Kilogram
USD $3.00-10.00 / Kilogram
USD $9.00-99.00 / Kilogram
USD $9.00-99.00 / Kilogram
USD $9.00-99.00 / Kilogram
USD $9.00-99.00 / Kilogram
USD $9.00-99.00 / Kilogram
product name: | 17-(3-pyridyl)-5,16-androstadien-3beta-acetate |
synonyms: | 17-(3-pyridyl)-5,16-androstadien-3beta-acetate;(3)-17-(3-pyridinyl)androsta-5,16-dien-3-ol acetate (ester);abiraterone acetate;cb 7630;abiraterone acetate(cb7630);3β-acetoxy-17-(3-pyridyl)androsta-5,16-diene;(3beta)-17-(3-pyridinyl)-androsta-5,16-dien-3-ol acetate (ester);2-((3s,8r,9s,10r,13s,14s)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl)acetate |
cas: | 154229-18-2 |
mf: | c26h33no2 |
mw: | 391.55 |
einecs: | |
product categories: | intermediates & fine chemicals;pharmaceuticals;steroids;api;dqm;inhibitor;final material;anti-cancer & immunity;inhibitors |
mol file: | 154229-18-2.mol |
17-(3-pyridyl)-5,16-androstadien-3beta-acetate chemical properties |
mp | 127-130°c |
storage temp. | -20°c freezer |
17-(3-pyridyl)-5,16-androstadien-3beta-acetate usage and synthesis |
chemical properties | off-white solid |
usage | abiraterone acetate is a novel steroidal inhibitor of human cytochrome p450 (17α-hydroxylase-c17,20-lyase): potential agent for the treatment of prostatic cancer. |
usage | a steroidal inhibitor of cyp17a1 in androgen biosynthesis |
usage | a novel steroidal inhibitor of human cytochrome p450(17a-hydroxylase-c17,20-lyase): potential agent for the treatment of prostatic cancer. |